Clinical TrialJun 23, 2026, 08:31 AM
Nexalin Study on Insomnia & Anxiety Wins Young Researcher Award
AI Summary
Dr. Victor Fontenelle Bastos de Lima, an investigator for Nexalin's Brazilian clinical study, received the Young Researcher Award at BRAIN 2026 for research on Nexalin's DIFS™ platform. The award-winning study evaluated the platform for insomnia symptoms in patients with comorbid anxiety, demonstrating significant and durable improvements in sleep quality. This independent scientific recognition strengthens the visibility of Nexalin's non-invasive neurostimulation platform as the company prepares for its product launch in Brazil, where it already holds ANVISA approval for anxiety, depression, and insomnia.
Key Highlights
- Dr. Victor Fontenelle Bastos de Lima received the Young Researcher Award at BRAIN 2026.
- Award recognized research on Nexalin’s DIFS™ 15 mA, 77.5 Hz platform.
- Research evaluated insomnia symptoms in patients with comorbid anxiety.
- Preliminary results showed significant, durable improvement in sleep quality.
- Nexalin has ANVISA approval in Brazil for anxiety, depression, and insomnia.
- Company is preparing for product launch of Nexalin SYNC in Brazil.
- Award provides independent scientific validation for Nexalin's technology.
Price Impact
More from NXL